Federal award
ROCHE DIAGNOSTICS CORPORATION
N6809421P6057
Contract
Obligated and Ceiling
- Obligated (net)
- $230,895.88
- Ceiling (potential value, not spending)
- $230,895.88
- Current value
- $230,895.88
- Gross positive obligations
- $230,895.88
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
- Awarding agency
- Department of War · sub-agency 1700 · office N68094
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- N6809421P6057
- Award type code
- B
- Actions
- 3 · Sep 27, 2021 to Dec 10, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History3
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 10, 2021 | FY2022 | P00002 | C | $173,171.91 | — |
| Oct 27, 2021 | FY2022 | P00001 | C | $57,723.97 | — |
| Sep 27, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.